Background In 2008, British Columbia (BC) implemented a school-based quadrivalent
human papillomavirus (HPV-4) immunization program for girls born in 1994 or later. In 2015 …

Introduction This study aimed to evaluate the early population impact of Ontario's school-
based human papillomavirus (HPV) vaccination program, implemented in September 2007 …

Background The incidence of anogenital warts (AGW) decreased after the introduction of the
quadrivalent human papillomavirus (qHPV) vaccine in multiple jurisdictions. We studied how …

In Québec province in Canada, a public school‐based and catch‐up HPV vaccination
programs with the quadrivalent vaccine have been introduced in September 2008 for girls …

Background We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Background Studies in countries with high human papillomavirus (HPV) vaccination
coverage have demonstrated marked reductions in anogenital wart (AGW) incidence. Our …

Objectives. We estimated anogenital wart prevalence from 2003 to 2010 by gender and age
group in a large US cohort with private insurance to detect potential decreases among …

Background Human papillomavirus (HPV) vaccination remains underused in the United
States, and few population-level studies on effectiveness exist. Methods We examined …

Background Anogenital warts (AGW) are caused by the most common sexually transmitted
infection, human papillomavirus. The objective of this study was to examine AGW incidence …

Background Assessing the impact and effectiveness of HPV vaccines on anogenital warts in
the United States can provide early indication of the success of vaccination programs as well …